Welcome to the “news” section of our website, where you'll find all the latest publications on our advances in research (Alzheimer's, Parkinson's, Charcot's disease, etc.), our upcoming events, etc.
Certain patients with multiple sclerosis (MS) can partially regenerate myelin—the protective sheath that surrounds nerve fibers—which is damaged during the evolution of the disease. In studying how immune cells influence this remyelination...
Multiple sclerosis is a heterogeneous disease whose manifestations vary considerably from patient to patient and whose course appears, on the surface, unpredictable. Hence, it is crucial to identify the factors that drive disability progression. In a...
What if the biological mechanisms that cause multiple sclerosis were triggered years before clinical diagnosis? This is what a team at Paris Brain Institute suggests in a new study published in Neurology. The researchers show that, on a population...
No treatment currently exists that can stop the silent progression of multiple sclerosis, and many promising drugs have proved ineffective in clinical trials. To reduce this failure rate and better predict the potential of candidate molecules...
In an article recently published in the European Journal of Neurology, Vito Ricigliano (AP-HP), Benedetta Bodini (AP-HP/Sorbonne University) and their collaborators at the Paris Brain Institute, demonstrate the protective effect of myelin repair on...
Several studies by Prof. Bruno Stankoff's team "Remyelination in multiple sclerosis: from biology to clinical translation", highlight new mechanisms of brain inflammation in multiple sclerosis, thanks to new imaging tools based on the combination of...
DOES MULTIPLE SCLEROSIS (MS) ALTER THE RISK OF DEVELOPING A SEVERE FORM OF COVID-19 INFECTION? WHAT ARE THE CLINICAL FEATURES AND EFFECTS OF CORONAVIRUS INFECTION IN PATIENTS WITH MS? DO SPECIFIC TREATMENTS FOR SEPSIS INCREASE OR DECREASE THE...
MSCopilot, a new multiple sclerosis self-assessment digital solution developed by AdScientiam a startup incubated at iPEPS, has been clinically validated in a clinical trial involving several French hospitals. The results are published in the...
Why does multiple sclerosis progress more rapidly in some patients than in others? Why do some patients with multiple sclerosis succeed in repairing demyelination damage over the course of the disease and others not? A joint study led by Institut du...
Myelin, a protective sheath that covers various nerve fibers, is essential in the transmission of nerve signals and enables proper function of the nervous system. Myelin degeneration causes severe illnesses including multiple sclerosis. Lamia...
The publication of Benedetta Bodini and Bruno Stankoff, researchers at Paris Brain Institute, on the use of a new imaging technique in multiple sclerosis, was selected by Lancet Neurology among the top 5 of 2016 to improve the understanding and...
Multiple sclerosis is an inflammatory disease of the nervous central system leading to a progressive destruction of the myelin sheath surrounding the axons, essential for their protection and for the transmission of the nerve impulse. Bruno Stankoff...
